Paromomycin Production Cost Reports

The report provides a detailed analysis essential for establishing a paromomycin production plant. It encompasses all critical aspects necessary for paromomycin production, including the cost of paromomycin production, paromomycin plant cost, paromomycin production costs, and the overall paromomycin production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a paromomycin production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Paromomycin is an aminoglycoside antibiotic which is obtained from Streptomyces rimosus var. paromomycinus. It works by binding to ribosomal RNA to disrupt protein synthesis in bacteria and protozoa. It is used orally for intestinal infections like amebiasis (Entamoeba histolytica), giardiasis, cryptosporidiosis, and tapeworms because of its poor systemic absorption. It also treats hepatic encephalopathy by reducing ammonia-producing gut bacteria. Its injectable forms serve as an alternative for visceral leishmaniasis, showing efficacy against resistant strains, while topical applications manage cutaneous leishmaniasis and trichomoniasis. It is also used in cryptosporidiosis in immunocompromised patients and has activity against drug-resistant tuberculosis.

The market for paromomycin is driven by rising parasitic infections like leishmaniasis and amebiasis. The R&D advancements, government efforts targeting neglected diseases, and improved healthcare infrastructure contribute to its demand. The Asia Pacific region shows the fastest expansion due to high disease cases, while North America leads because of advanced systems. The industrial paromomycin procurement is affected by supply-demand disparities caused by minimum batch sizes and scarce manufacturers. The stockouts, delays, and emergency sourcing, particularly for cutaneous leishmaniasis treatments, with API prices varying because of supply chain issues and geopolitical factors, further impact its sourcing.

Raw Material for Paromomycin Production

According to the paromomycin production plant project report, the key raw materials used in the production of paromomycin include Streptomyces rimosus subsp. paromomycinus producer strain and fermentation medium.

Production Process of Paromomycin

The extensive paromomycin production cost report consists of the following major industrial production process:

1. By Fermentation: The production of paromomycin involves fermentation of Streptomyces rimosus subsp. paromomycinus. It starts with preparing a seed culture of the producing microorganism in a nutrient broth. It is transferred into an optimised production medium containing soybean meal as nitrogen source, glycerol as carbon source, ammonium chloride and calcium carbonate, and adjusted to an appropriate pH. The fermentation is conducted under controlled temperature and agitation conditions to promote antibiotic biosynthesis. After that, the culture broth is processed, and the antibiotic is separated from the fermentation liquid to get paromomycin.

Paromomycin is an aminoglycoside antibiotic with the molecular formula C23H45N5O14 and molecular weight of 615.634 g/mol. It appears as an off-white to light yellow, amorphous, hygroscopic, odourless powder. It shows high water solubility, with collision cross-sections of 239.1 Ų for [M+H]⁺ and 237.7 Ų for [M+Na]⁺. It has an amino cyclitol glycoside structure with multiple amino and hydroxyl groups, partly existing as paromomycin(5+) at 620.7 g/mol. This chemical stability supports its use in oral and topical formulations for treating parasitic infections. Its ribosomal binding provides strong antibacterial and antiprotozoal activity, making it useful as an antibiotic.